ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 719690 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 719690; 2) Community: the network communities that were significantly associated with the response to NSC 719690; 3) Molecule: the relationships between components within communities and NSC 719690; 4) MDR: the compounds that were significantly associated with the NSC 719690.

NSC Compound Enrichment Correlation
NSC 736049 N-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N'-(2-met hylimidazo[1,2-a]pyridin-3-yl)urea 0.0438391811600418 0.37231925
NSC 740275 5,6-Dihydro-6-(3-morpholinyl-1-propyl)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0438391811600418 0.42035205
NSC 741738 1-(7-Methoxy-3-methyl-1,4-dioxy-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.0438391811600418 0.27305394
NSC 102051 Null 0.0478540623811426 0.29567743
NSC 104801 Cytembena 0.0478540623811426 -0.065927425
NSC 113423 NSC 113423 0.0478540623811426 -0.0069067807
NSC 132277 Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) 0.0478540623811426 -0.039028987
NSC 13484 Null 0.0478540623811426 -0.10276036
NSC 176323 Camptothecin Derivative 0.0478540623811426 0.12585643
NSC 295499 Camptothecin Derivative 0.0478540623811426 0.12214144
Total:65  Current:60    [First] [Prev] [Next] [Last]